You are here: Industry Insights > cancer

News List

Australian scientists detect cancer with gold plated nanoparticles biospectrumasia
October 15, 2018
During the study, the researchers altered gold-coated nanoparticles using DNA to match the miRNA to be detected.
Gov’t unveils intent to improve cancer diagnosis pharmatimes
October 11, 2018
The government has announced plans to improve the diagnosis of cancer, with the aim of detecting three out of four cases at an early stage by 2028.
FDA Approves Dacomitinib for Metastatic Non-Small Cell Lung Cancer americanpharmaceuticalreview
September 29, 2018
The Food and Drug Administration (FDA) has approved dacomitinib tablets (VIZIMPRO, Pfizer Pharmaceutical Company) for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon
Roche aims to improve cancer treatments with DNA blood test pharmaphorum
September 27, 2018
Roche has launched a blood test that can identify 70 of the most commonly mutated genes in solid tumours, as the company seeks to make more medicine more personalised.
Merck and Pfizer trial cancer combination with Australia’s Immutep pharmaphorum
September 27, 2018
Australian biotech Immutep has begun a clinical trial partnership with Germany’s Merck KGaA and Pfizer to develop a new cancer immunotherapy combination therapy.
Daiichi to test cancer drug combo pharmatimes
September 21, 2018
Daiichi Sankyo has entered into a clinical trial collaboration agreement with a subsidiary of MSD to evaluate a potential new combination therapy for breast or lung cancers.
FDA approves AstraZeneca’s Lumoxiti for hairy cell leukaemia (HCL) pharmafile
September 20, 2018
AstraZeneca’s Lumoxiti has been approved for use for the treatment of relapsed or refractory hairy cell leukemia (HCL)in adults who have had at least two prior therapies for the disease.
Cancer Research UK announces new £14m research hub in London pharmafile
September 20, 2018
Cancer Research UK has announced a £14 million investment to build a new hub in London for cancer research and treatment to create “a global centre...
CR UK invests £14m in London cancer biotherapeutics hub pharmatimes
September 20, 2018
Cancer Research UK is investing some £14 million into transforming the city of London into a “world-leading hub for cancer biotherapeutics”.
Boehringer buys ViraTherapeutics pharmatimes
September 18, 2018
Boehringer Ingelheim has exercised an option to acquire all shares of oncolytic virus company ViraTherapeutics.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 88 89 Next page